Healthcare Biometrics Market is Expected to Reach USD 5.8 Billion Globally in 2019



Transparency Market Research is Published new Market Report " Healthcare Biometrics Market (Fingerprint, Face, Iris, Voice, Vein, Signature and Hand Recognition Technologies, Logical Access Control, Physical Access Control and Transaction Authentication Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global healthcare biometrics market was valued at USD 1.2 billion in 2012 and is expected to grow at a CAGR of 25.9% from 2013 to 2019, to reach an estimated value of USD 5.8 billion in 2019.

Biometrics is used to identify and authenticate an individual's identity by their biological characteristics or traits. This technology is used in the healthcare industry for the purpose of patient and medical staff's verification and access control. Use of biometric identity solutions reflects prevention and minimization of healthcare fraud and resource wastage while also improving healthcare safety, quality and patient privacy. Rapid technological advancements in healthcare infrastructure, increasing accuracy and performance levels, along with reduced complexity and cost of biometric devices are some of the major factors driving the biometrics growth in healthcare. Furthermore, growing preference for reducing healthcare expenditure by minimizing the risk of security breaches and medical identity thefts with the use of biometrics, support the growing acceptance of biometric systems in the healthcare industry worldwide.Growing security concerns with healthcare facilities and medical insurance providers has impelled the demand for biometrics solutions in healthcare.

The global healthcare biometrics market can be categorized into biometric technologies and their applications in various authentication processes. Fingerprint recognition technology is the most prominently used biometric technology and will make up more than 50% percent of biometrics demand in healthcare industry through 2019. Availability of a wide range of fingerprint recognition devices, introduction of portable fingerprint scanners and their efficacy in healthcare are the major factors driving the demand for fingerprint technology. Based on adaptability to cost effective security enhanced formats, AFIS (automated fingerprint identification systems), will continue to lead in terms of market revenues. It is expected that the global market for fingerprint biometric devices will grow at a CAGR of more than 20% from 2013 to 2019.

On the other hand, vein, face and iris recognition are expected to witness fastest growth among the other biometric technologies and will account for the most rapidly expanding demand from applications in the logical access control. Demand for these products will benefit from more strict government regulations and industry standards covering the safety, security, and functional features of biometric systems. Logical access control, physical access control and transaction authentication are the three prime application areas of healthcare biometrics. Use of logical access is essential for user's authentication to permit access to computer systems in hospitals and healthcare facilities. Thus, in terms of allocations, logical access control segment is expected to dominate the global healthcare biometrics market during the given forecast period of 2013 to 2019.

Geographically, North America is expected to remain the largest market for healthcare biometrics technologies. Currently, North America along with Europe captures more than 75% of the market share. In the developing world, Asia-Pacific region will provide the largest and most diverse sales opportunities for biometrics security solutions in the healthcare sector due to budding domestic and export markets for nationally produced biometric devices.

The healthcare biometrics market is highly fragmented and consists of many large and small players. The competition in this market is characterized by market consolidation activities, partnerships, and intensive mergers and acquisitions as well as intensive cost-containment measures. Some of the major companies currently active in the healthcare biometrics market include 3M Cogent, Inc., Bio-Key International, Inc., DigitalPersona, Inc., NEC Corporation, M2SYS LLC, Cross Match Technologies, Inc., Suprema, Inc., and Siemens AG.

The global healthcare biometrics market is segmented as follows:

Healthcare Biometrics Market, by Technology
  • Fingerprint
  • Vein
  • Face
  • Iris
  • Voice
  • Hand
  • Signature
  • Others
Healthcare Biometrics Market, by Applications
  • Logical Access Control
  • Physical Access Control
  • Transaction Authentication
Healthcare Biometrics Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

TABLE OF CONTENTS

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary


Chapter 3 Market Overview
3.1 Market Definition and Overview
      3.1.1 The biometrics industry
      3.1.2 The need for biometrics
      3.1.3 Biometrics benefits offered in healthcare
3.2 Market Dynamics
      3.2.1 Drivers
               3.2.1.1 Financial benefits offered by healthcare biometrics
               3.2.1.2 Reduction in healthcare frauds
               3.2.1.3 Practical alternative to passwords
      3.2.2 Restraints
               3.2.2.1 Storage of biometric template
               3.2.2.2 Security and convenience trade-off
      3.2.3 Opportunities
               3.2.3.1 Biometric self-service in healthcare
               3.2.3.2 Future scope in palm vein biometric authentication
3.3 Porter’s Five Force Analysis
      3.3.1 Bargaining Power of Suppliers
      3.3.2 Bargaining Power of Buyers
      3.3.3 Threat of New Entrants
      3.3.4 Threat of Substitutes
      3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis: Global Healthcare Biometrics Market, by Geography, 2012

Chapter 4 Global Healthcare Biometrics Market, by Technology
4.1 Overview
4.2 Face Recognition
      4.2.1 Global Face Recognition Biometrics Market Revenue, 2011 – 2019 (USD Million)
4.3 Iris Recognition
      4.3.1 Global Iris Recognition Biometrics Market Revenue, 2011 – 2019 (USD Million)
4.4 Hand Recognition
      4.4.1 Global Hand Recognition Biometrics Market Revenue, 2011 – 2019 (USD Million)
4.5 Voice Recognition
      4.5.1 Global Voice Recognition Biometrics Market Revenue, 2011 – 2019 (USD Million)
4.6 Fingerprint Recognition
      4.6.1 Global Fingerprint Recognition Biometrics Market Revenue, 2011 – 2019 (USD Million)
      4.6.2 Automated Fingerprint Identification Systems (AFIS)
      4.6.3 Global AFIS Biometrics Market Revenue, 2011 – 2019 (USD Million)
      4.6.4 Non-Automated Fingerprint Identification Systems (Non-AFIS)
      4.6.5 Global Non-AFIS Biometrics Market Revenue, 2011 – 2019 (USD Million)
4.7 Vein Recognition
      4.7.1 Global Vein Recognition Biometrics Market Revenue, 2011 – 2019 (USD Million)
4.8 Signature Recognition
      4.8.1 Global Signature Recognition Biometrics Market Revenue, 2011 – 2019 (USD Million)
4.9 Other Techniques


Chapter 5 Global Healthcare Biometrics Market, by Applications
5.1 Overview
5.2 Logical Access Control
      5.2.1 Logical Access Control Biometrics Market Revenue, 2011 – 2019 (USD Million)
5.3 Physical Access Control
      5.3.1 Physical Access Control Biometrics Market Revenue, 2011 – 2019 (USD Million)
5.4 Transaction Authentication
      5.4.1 Transaction Authentication Biometrics Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Global Healthcare Biometrics Market, by Geography
6.1 Overview
      6.1.1 Comparative Analysis, Global Healthcare Biometrics Market, by Geography, 2012 – 2019 (Value %)

6.2 North America
      6.2.1 North America Healthcare Biometrics Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe Healthcare Biometrics Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Healthcare Biometrics Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 Rest of the World (RoW) Healthcare Biometrics Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Recommendations
Chapter 8 Company Profiles
8.1 3M Cogent, Inc.
      8.1.1 Company Overview
      8.1.2 Business Strategy
      8.1.3 Financial Overview
      8.1.4 Product Portfolio
      8.1.5 Recent Developments
8.2 Aware, Inc.
      8.2.1 Company Overview
      8.2.2 Strategic Overview
      8.2.3 Financial Overview
      8.2.4 Product Portfolio
      8.2.5 Recent Developments
8.3 BIO-key International, Inc.
      8.3.1 Company Overview
      8.3.2 Business Strategy
      8.3.3 Financial Overview
      8.3.4 Product Portfolio
      8.3.5 Recent Developments
8.4 Cross Match Technologies, Inc.
      8.4.1 Company Overview
      8.4.2 Strategic Overview
      8.4.3 Financial Overview
      8.4.4 Product Portfolio
      8.4.5 Recent Developments
8.5 DigitalPersona, Inc.
      8.5.1 Company Overview
      8.5.2 Strategic Overview
      8.5.3 Financial Overview
      8.5.4 Product Portfolio
      8.5.5 Recent Developments
8.6 Fujitsu Ltd.
      8.6.1 Company Overview
      8.6.2 Strategic Overview
      8.6.3 Financial Overview
      8.6.4 Product Portfolio
      8.6.5 Recent Developments
8.7 Lumidigm, Inc.
      8.7.1 Company Overview
      8.7.2 Strategic Overview
     8.7.3 Financial Overview
      8.7.4 Product Portfolio
      8.7.5 Recent Developments
8.8 M2SYS LLC
      8.8.1 Company Overview
      8.8.2 Strategic Overview
      8.8.3 Financial Overview
      8.8.4 Product Portfolio
      8.8.5 Recent Developments
8.9 NEC Corporation
      8.9.1 Company Overview
      8.9.2 Strategic Overview
      8.9.3 Financial Overview
      8.9.4 Product Portfolio
      8.9.5 Recent Developments
8.10 SAFRAN SA
      8.10.1 Company Overview
      8.10.2 Strategic Overview
      8.10.3 Financial Overview
      8.10.4 Product Portfolio
      8.10.5 Recent Developments
8.11 Siemens AG
      8.11.1 Company Overview
      8.11.2 Strategic Overview
      8.11.3 Financial Overview
      8.11.4 Product Portfolio
      8.11.5 Recent Developments
8.12 Suprema, Inc.
      8.12.1 Company Overview
      8.12.2 Strategic Overview
      8.12.3 Financial Overview
      8.12.4 Product Portfolio
      8.12.5 Recent Developments
8.13 ZKTeco, Inc.
      8.13.1 Company Overview
      8.13.2 Strategic Overview
      8.13.3 Financial Overview
      8.13.4 Product Portfolio
      8.13.5 Recent Developments

» Read More...

Enteric Disease Testing Market is Expected to Reach to USD 3.6 Billion Globally by 2019: Transparency Market Research


Transparency Market Research is Published new Market Report " Enteric Disease Testing Market (Amebiasis, C.difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.coli Infection, Giardiasis, H.pylori Infection, Norovirus Infection, Rotavirus Infection, Salmonellosis and Shigellosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global enteric disease testing market was valued at USD 3.1 billion in 2012 and is expected to grow at a CAGR of 2.4% from 2013 to 2019, to reach an estimated value of USD 3.6 billion in 2019.


Enteric diseases are major causes of morbidity and mortality worldwide. Developing socio-economic countries with poor drainage, sanitation along with overcrowding and low hygiene awareness account for majority of enteric infection incidences prevailing worldwide. These diseases usually exhibit mild symptoms but if not treated on time can lead to severe complications, resulting in death. In order to manage these diseases effectively, their early detection is essential. Various enteric diseases responsible for diarrhea, stomach pain, nausea, vomiting, anorexia, weight loss and fever are amebiasis, giardiasis, rotavirus infection, salmonellosis and shigellosis.

Traditionally, diagnosis of enteric infections relied on culture results of fecal specimen. Today, the world is witnessing a paradigm shift from culture to EIA (enzyme immunoassaya) and PCR (polymerase chain reaction) based tests owing to advantages associated with these newer testing methods. EIA and PCR tests offer enhanced sensitivity and specificity compared to culture tests and also give quick results. Globally the market for enteric disease testing is growing at a CAGR of 2.4% under the influence of rising awareness, demand for point of care testing and increasing application of molecular diagnostics. Use of molecular diagnostic products has made diagnosis easy and possible, even those strains which once seemed to be difficult and impossible. North America and Europe represent the largest regional markets because of rapid demand for molecular based diagnostics and due to high level of awareness among people about the diseases. C.difficile infection is one of the major causes of antibiotic related diarrhea in developed regions.

Various epidemiological sources including CDC and American Association for Clinical Chemistry suggest that C.difficile infection incidence per 100,000 people has increased over the past few decades in United States. In developing nations, frequent travelling to regions where enteric diseases are epidemic is also one of the reasons driving the market growth. Asia-Pacific and Africa have been predicted to grow rapidly during the forecast period. In developing nations of Asia-pacific, Africa and Latin America, the market is also growing due to advent of rapid dipstick tests which can be applied by the patient themself. These regions associated with inadequate healthcare infrastructure do not possess substantial number of laboratories to perform laboratory based tests.

Thus, rapid dipstick test kits being inexpensive and easy to use are widely accepted in these regions for managing enteric illness. Continuously improving economy and rising healthcare expenditure in these regions are also anticipated to drive the market. The market is also growing due to emergence of new strains; sources from Eurosurveillance suggest that the norovirus infection is increasing worldwide, including United Kingdom, the Netherlands, France, Japan and Australia due to emergence of new strain of genotype II.4 (GII.4) that is also known as Sydney strain.

Some of the major companies leading the market for enteric disease testing are DiaSorin, Cepheid, Bio-Rad, Trinity Biotech, Biomerica, Becton Dickinson, Meridian Bioscience, Alere and bioMerieux.

The global enteric disease testing market is segmented into the following categories:

Enteric Disease Testing Market, by types of diseases
  • Bacterial Enteric Disease Testing
    • C.difficile Infection
    • Campylobacteriosis
    • Cholera
    • E.coli Infection
    • H.pylori Infection
    • Salmonellosis
    • Shigellosis
  • Viral Enteric Disease Testing
    • Rotavirus Infection
    • Norovirus Infection
  • Parasitic Enteric Disease Testing
    • Amebiasis
    • Cryptosporidiosis
    • Giardiasis
Enteric Disease Testing Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Africa
  • Latin America
  • Rest of the World (RoW)

» Read More...

Search This Blog

About Me

My photo

The dedicated team of researchers and analysts at Business Research Industry into the Advantage of Knowledge for your company. Data becomes knowledge through the application of Dolcera's optimization process as follows.

Archives

Business Research Industry. Powered by Blogger.